The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. This report only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.
China is the world's largest producer and consumer of Antibiotic API, with sales accounting for more than 15% of the global market share. At present, major global manufacturers include UNITED LABORATORIES, North China Pharmaceutical, Centrient Pharmaceuticals, Shyndec Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, Aurobindo Pharma, etc. The top five manufacturers account for more than 25%. Antibiotic API mainly include penicillins, cephalosporins, aminoglycosides, tetracyclines, etc., which are administered orally or by injection.
The global Antibiotic API market was valued at US$ 5626.1 million in 2020 and is expected to reach US$ 5290.7 million by the end of 2027, growing at a CAGR of -0.9% during 2021-2027.
This report focuses on Antibiotic API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antibiotic API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Antibiotic API Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Segment by Application
Oral Medicine
Injection Medicine
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. This report only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.
China is the world's largest producer and consumer of Antibiotic API, with sales accounting for more than 15% of the global market share. At present, major global manufacturers include UNITED LABORATORIES, North China Pharmaceutical, Centrient Pharmaceuticals, Shyndec Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, Aurobindo Pharma, etc. The top five manufacturers account for more than 25%. Antibiotic API mainly include penicillins, cephalosporins, aminoglycosides, tetracyclines, etc., which are administered orally or by injection.
The global Antibiotic API market was valued at US$ 5626.1 million in 2020 and is expected to reach US$ 5290.7 million by the end of 2027, growing at a CAGR of -0.9% during 2021-2027.
This report focuses on Antibiotic API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antibiotic API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Antibiotic API Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Segment by Application
Oral Medicine
Injection Medicine
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
Index1 Antibiotic API Market Overview
1.1 Product Overview and Scope of Antibiotic API
1.2 Antibiotic API Segment by Type
1.2.1 Global Antibiotic API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Penicillins
1.2.3 Cephalosporins
1.2.4 Aminoglycosides
1.2.5 Tetracyclines
1.2.6 Quinolones
1.2.7 Macrolides
1.2.8 Lincomycins
1.2.9 Others
1.3 Antibiotic API Segment by Application
1.3.1 Global Antibiotic API Sales Comparison by Application: (2021-2027)
1.3.2 Oral Medicine
1.3.3 Injection Medicine
1.4 Global Antibiotic API Market Size Estimates and Forecasts
1.4.1 Global Antibiotic API Revenue 2016-2027
1.4.2 Global Antibiotic API Sales 2016-2027
1.4.3 Antibiotic API Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibiotic API Market Competition by Manufacturers
2.1 Global Antibiotic API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibiotic API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibiotic API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibiotic API Manufacturing Sites, Area Served, Product Type
2.5 Antibiotic API Market Competitive Situation and Trends
2.5.1 Antibiotic API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibiotic API Players Market Share by Revenue
2.5.3 Global Antibiotic API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibiotic API Retrospective Market Scenario by Region
3.1 Global Antibiotic API Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antibiotic API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antibiotic API Market Facts & Figures by Country
3.3.1 North America Antibiotic API Sales by Country
3.3.2 North America Antibiotic API Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibiotic API Market Facts & Figures by Country
3.4.1 Europe Antibiotic API Sales by Country
3.4.2 Europe Antibiotic API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibiotic API Market Facts & Figures by Region
3.5.1 Asia Pacific Antibiotic API Sales by Region
3.5.2 Asia Pacific Antibiotic API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Antibiotic API Market Facts & Figures by Country
3.6.1 Latin America Antibiotic API Sales by Country
3.6.2 Latin America Antibiotic API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibiotic API Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibiotic API Sales by Country
3.7.2 Middle East and Africa Antibiotic API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antibiotic API Historic Market Analysis by Type
4.1 Global Antibiotic API Sales Market Share by Type (2016-2021)
4.2 Global Antibiotic API Revenue Market Share by Type (2016-2021)
4.3 Global Antibiotic API Price by Type (2016-2021)
5 Global Antibiotic API Historic Market Analysis by Application
5.1 Global Antibiotic API Sales Market Share by Application (2016-2021)
5.2 Global Antibiotic API Revenue Market Share by Application (2016-2021)
5.3 Global Antibiotic API Price by Application (2016-2021)
6 Key Companies Profiled
6.1 UNITED LABORATORIES
6.1.1 UNITED LABORATORIES Corporation Information
6.1.2 UNITED LABORATORIES Description and Business Overview
6.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 UNITED LABORATORIES Antibiotic API Product Portfolio
6.1.5 UNITED LABORATORIES Recent Developments/Updates
6.2 North China Pharmaceutical
6.2.1 North China Pharmaceutical Corporation Information
6.2.2 North China Pharmaceutical Description and Business Overview
6.2.3 North China Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 North China Pharmaceutical Antibiotic API Product Portfolio
6.2.5 North China Pharmaceutical Recent Developments/Updates
6.3 RUIYING PIONEER PHARMACEUTICAL
6.3.1 RUIYING PIONEER PHARMACEUTICAL Corporation Information
6.3.2 RUIYING PIONEER PHARMACEUTICAL Description and Business Overview
6.3.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio
6.3.5 RUIYING PIONEER PHARMACEUTICAL Recent Developments/Updates
6.4 Centrient Pharmaceuticals
6.4.1 Centrient Pharmaceuticals Corporation Information
6.4.2 Centrient Pharmaceuticals Description and Business Overview
6.4.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Centrient Pharmaceuticals Antibiotic API Product Portfolio
6.4.5 Centrient Pharmaceuticals Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Aurobindo Pharma Antibiotic API Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Shyndec Pharmaceutical
6.6.1 Shyndec Pharmaceutical Corporation Information
6.6.2 Shyndec Pharmaceutical Description and Business Overview
6.6.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Shyndec Pharmaceutical Antibiotic API Product Portfolio
6.6.5 Shyndec Pharmaceutical Recent Developments/Updates
6.7 Nectar Lifesciences
6.6.1 Nectar Lifesciences Corporation Information
6.6.2 Nectar Lifesciences Description and Business Overview
6.6.3 Nectar Lifesciences Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nectar Lifesciences Antibiotic API Product Portfolio
6.7.5 Nectar Lifesciences Recent Developments/Updates
6.8 Harbin Pharmaceutical Group
6.8.1 Harbin Pharmaceutical Group Corporation Information
6.8.2 Harbin Pharmaceutical Group Description and Business Overview
6.8.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Harbin Pharmaceutical Group Antibiotic API Product Portfolio
6.8.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.9 ACS Dobfar
6.9.1 ACS Dobfar Corporation Information
6.9.2 ACS Dobfar Description and Business Overview
6.9.3 ACS Dobfar Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ACS Dobfar Antibiotic API Product Portfolio
6.9.5 ACS Dobfar Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Novartis Antibiotic API Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 CSPC
6.11.1 CSPC Corporation Information
6.11.2 CSPC Antibiotic API Description and Business Overview
6.11.3 CSPC Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.11.4 CSPC Antibiotic API Product Portfolio
6.11.5 CSPC Recent Developments/Updates
6.12 QILU ANTIBIOTICS PHARMACEUTICAL
6.12.1 QILU ANTIBIOTICS PHARMACEUTICAL Corporation Information
6.12.2 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Description and Business Overview
6.12.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.12.4 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio
6.12.5 QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments/Updates
6.13 REYOUNG
6.13.1 REYOUNG Corporation Information
6.13.2 REYOUNG Antibiotic API Description and Business Overview
6.13.3 REYOUNG Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.13.4 REYOUNG Antibiotic API Product Portfolio
6.13.5 REYOUNG Recent Developments/Updates
6.14 Orchid Pharma
6.14.1 Orchid Pharma Corporation Information
6.14.2 Orchid Pharma Antibiotic API Description and Business Overview
6.14.3 Orchid Pharma Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Orchid Pharma Antibiotic API Product Portfolio
6.14.5 Orchid Pharma Recent Developments/Updates
6.15 FUAN PHARMACEUTICAL
6.15.1 FUAN PHARMACEUTICAL Corporation Information
6.15.2 FUAN PHARMACEUTICAL Antibiotic API Description and Business Overview
6.15.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.15.4 FUAN PHARMACEUTICAL Antibiotic API Product Portfolio
6.15.5 FUAN PHARMACEUTICAL Recent Developments/Updates
6.16 Dongying Pharmaceutical
6.16.1 Dongying Pharmaceutical Corporation Information
6.16.2 Dongying Pharmaceutical Antibiotic API Description and Business Overview
6.16.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Dongying Pharmaceutical Antibiotic API Product Portfolio
6.16.5 Dongying Pharmaceutical Recent Developments/Updates
6.17 FUKANG PHARMACEUTICAL
6.17.1 FUKANG PHARMACEUTICAL Corporation Information
6.17.2 FUKANG PHARMACEUTICAL Antibiotic API Description and Business Overview
6.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.17.4 FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
6.17.5 FUKANG PHARMACEUTICAL Recent Developments/Updates
6.18 Medya Pharmaceutical
6.18.1 Medya Pharmaceutical Corporation Information
6.18.2 Medya Pharmaceutical Antibiotic API Description and Business Overview
6.18.3 Medya Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Medya Pharmaceutical Antibiotic API Product Portfolio
6.18.5 Medya Pharmaceutical Recent Developments/Updates
6.19 LUKANG PHARMACEUTICAL
6.19.1 LUKANG PHARMACEUTICAL Corporation Information
6.19.2 LUKANG PHARMACEUTICAL Antibiotic API Description and Business Overview
6.19.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.19.4 LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
6.19.5 LUKANG PHARMACEUTICAL Recent Developments/Updates
6.20 Dawnrays Pharmaceutical
6.20.1 Dawnrays Pharmaceutical Corporation Information
6.20.2 Dawnrays Pharmaceutical Antibiotic API Description and Business Overview
6.20.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Dawnrays Pharmaceutical Antibiotic API Product Portfolio
6.20.5 Dawnrays Pharmaceutical Recent Developments/Updates
6.21 SALUBRIS
6.21.1 SALUBRIS Corporation Information
6.21.2 SALUBRIS Antibiotic API Description and Business Overview
6.21.3 SALUBRIS Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.21.4 SALUBRIS Antibiotic API Product Portfolio
6.21.5 SALUBRIS Recent Developments/Updates
6.22 KELUN
6.22.1 KELUN Corporation Information
6.22.2 KELUN Antibiotic API Description and Business Overview
6.22.3 KELUN Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.22.4 KELUN Antibiotic API Product Portfolio
6.22.5 KELUN Recent Developments/Updates
6.23 HUAFANG PHARMACEUTICAL
6.23.1 HUAFANG PHARMACEUTICAL Corporation Information
6.23.2 HUAFANG PHARMACEUTICAL Antibiotic API Description and Business Overview
6.23.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2016-2021)
6.23.4 HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio
6.23.5 HUAFANG PHARMACEUTICAL Recent Developments/Updates
7 Antibiotic API Manufacturing Cost Analysis
7.1 Antibiotic API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibiotic API
7.4 Antibiotic API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibiotic API Distributors List
8.3 Antibiotic API Customers
9 Antibiotic API Market Dynamics
9.1 Antibiotic API Industry Trends
9.2 Antibiotic API Growth Drivers
9.3 Antibiotic API Market Challenges
9.4 Antibiotic API Market Restraints
10 Global Market Forecast
10.1 Antibiotic API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibiotic API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibiotic API by Type (2022-2027)
10.2 Antibiotic API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibiotic API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibiotic API by Application (2022-2027)
10.3 Antibiotic API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibiotic API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibiotic API by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Antibiotic API Sales (Tons) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibiotic API Sales (Tons) Comparison by Application (2021-2027)
Table 3. Global Antibiotic API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibiotic API Covered in This Study
Table 5. Global Antibiotic API Sales (Tons) of Key Manufacturers (2016-2021)
Table 6. Global Antibiotic API Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antibiotic API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibiotic API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibiotic API Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibiotic API Manufacturing Sites and Area Served
Table 11. Manufacturers Antibiotic API Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibiotic API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibiotic API Sales by Region (2016-2021) & (Tons)
Table 16. Global Antibiotic API Sales Market Share by Region (2016-2021)
Table 17. Global Antibiotic API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 19. North America Antibiotic API Sales Market Share by Country (2016-2021)
Table 20. North America Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibiotic API Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 23. Europe Antibiotic API Sales Market Share by Country (2016-2021)
Table 24. Europe Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibiotic API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibiotic API Sales by Region (2016-2021) & (Tons)
Table 27. Asia Pacific Antibiotic API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibiotic API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibiotic API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 31. Latin America Antibiotic API Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibiotic API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 35. Middle East and Africa Antibiotic API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibiotic API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibiotic API Revenue Market Share by Country (2016-2021)
Table 38. Global Antibiotic API Sales (Tons) by Type (2016-2021)
Table 39. Global Antibiotic API Sales Market Share by Type (2016-2021)
Table 40. Global Antibiotic API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibiotic API Revenue Share by Type (2016-2021)
Table 42. Global Antibiotic API Price (USD/Kg) by Type (2016-2021)
Table 43. Global Antibiotic API Sales (Tons) by Application (2016-2021)
Table 44. Global Antibiotic API Sales Market Share by Application (2016-2021)
Table 45. Global Antibiotic API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibiotic API Revenue Share by Application (2016-2021)
Table 47. Global Antibiotic API Price (USD/Kg) by Application (2016-2021)
Table 48. UNITED LABORATORIES Corporation Information
Table 49. UNITED LABORATORIES Description and Business Overview
Table 50. UNITED LABORATORIES Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. UNITED LABORATORIES Antibiotic API Product
Table 52. UNITED LABORATORIES Recent Developments/Updates
Table 53. North China Pharmaceutical Corporation Information
Table 54. North China Pharmaceutical Description and Business Overview
Table 55. North China Pharmaceutical Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. North China Pharmaceutical Antibiotic API Product
Table 57. North China Pharmaceutical Recent Developments/Updates
Table 58. RUIYING PIONEER PHARMACEUTICAL Corporation Information
Table 59. RUIYING PIONEER PHARMACEUTICAL Description and Business Overview
Table 60. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product
Table 62. RUIYING PIONEER PHARMACEUTICAL Recent Developments/Updates
Table 63. Centrient Pharmaceuticals Corporation Information
Table 64. Centrient Pharmaceuticals Description and Business Overview
Table 65. Centrient Pharmaceuticals Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Centrient Pharmaceuticals Antibiotic API Product
Table 67. Centrient Pharmaceuticals Recent Developments/Updates
Table 68. Aurobindo Pharma Corporation Information
Table 69. Aurobindo Pharma Description and Business Overview
Table 70. Aurobindo Pharma Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Aurobindo Pharma Antibiotic API Product
Table 72. Aurobindo Pharma Recent Developments/Updates
Table 73. Shyndec Pharmaceutical Corporation Information
Table 74. Shyndec Pharmaceutical Description and Business Overview
Table 75. Shyndec Pharmaceutical Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Shyndec Pharmaceutical Antibiotic API Product
Table 77. Shyndec Pharmaceutical Recent Developments/Updates
Table 78. Nectar Lifesciences Corporation Information
Table 79. Nectar Lifesciences Description and Business Overview
Table 80. Nectar Lifesciences Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Nectar Lifesciences Antibiotic API Product
Table 82. Nectar Lifesciences Recent Developments/Updates
Table 83. Harbin Pharmaceutical Group Corporation Information
Table 84. Harbin Pharmaceutical Group Description and Business Overview
Table 85. Harbin Pharmaceutical Group Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Harbin Pharmaceutical Group Antibiotic API Product
Table 87. Harbin Pharmaceutical Group Recent Developments/Updates
Table 88. ACS Dobfar Corporation Information
Table 89. ACS Dobfar Description and Business Overview
Table 90. ACS Dobfar Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. ACS Dobfar Antibiotic API Product
Table 92. ACS Dobfar Recent Developments/Updates
Table 93. Novartis Corporation Information
Table 94. Novartis Description and Business Overview
Table 95. Novartis Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Novartis Antibiotic API Product
Table 97. Novartis Recent Developments/Updates
Table 98. CSPC Corporation Information
Table 99. CSPC Description and Business Overview
Table 100. CSPC Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. CSPC Antibiotic API Product
Table 102. CSPC Recent Developments/Updates
Table 103. QILU ANTIBIOTICS PHARMACEUTICAL Corporation Information
Table 104. QILU ANTIBIOTICS PHARMACEUTICAL Description and Business Overview
Table 105. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product
Table 107. QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments/Updates
Table 108. REYOUNG Corporation Information
Table 109. REYOUNG Description and Business Overview
Table 110. REYOUNG Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. REYOUNG Antibiotic API Product
Table 112. REYOUNG Recent Developments/Updates
Table 113. Orchid Pharma Corporation Information
Table 114. Orchid Pharma Description and Business Overview
Table 115. Orchid Pharma Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Orchid Pharma Antibiotic API Product
Table 117. Orchid Pharma Recent Developments/Updates
Table 118. FUAN PHARMACEUTICAL Corporation Information
Table 119. FUAN PHARMACEUTICAL Description and Business Overview
Table 120. FUAN PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. FUAN PHARMACEUTICAL Antibiotic API Product
Table 122. FUAN PHARMACEUTICAL Recent Developments/Updates
Table 123. Dongying Pharmaceutical Corporation Information
Table 124. Dongying Pharmaceutical Description and Business Overview
Table 125. Dongying Pharmaceutical Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Dongying Pharmaceutical Antibiotic API Product
Table 127. Dongying Pharmaceutical Recent Developments/Updates
Table 128. FUKANG PHARMACEUTICAL Corporation Information
Table 129. FUKANG PHARMACEUTICAL Description and Business Overview
Table 130. FUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. FUKANG PHARMACEUTICAL Antibiotic API Product
Table 132. FUKANG PHARMACEUTICAL Recent Developments/Updates
Table 133. Medya Pharmaceutical Corporation Information
Table 134. Medya Pharmaceutical Description and Business Overview
Table 135. Medya Pharmaceutical Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Medya Pharmaceutical Antibiotic API Product
Table 137. Medya Pharmaceutical Recent Developments/Updates
Table 138. LUKANG PHARMACEUTICAL Corporation Information
Table 139. LUKANG PHARMACEUTICAL Description and Business Overview
Table 140. LUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. LUKANG PHARMACEUTICAL Antibiotic API Product
Table 142. LUKANG PHARMACEUTICAL Recent Developments/Updates
Table 143. Dawnrays Pharmaceutical Corporation Information
Table 144. Dawnrays Pharmaceutical Description and Business Overview
Table 145. Dawnrays Pharmaceutical Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. Dawnrays Pharmaceutical Antibiotic API Product
Table 147. Dawnrays Pharmaceutical Recent Developments/Updates
Table 148. SALUBRIS Corporation Information
Table 149. SALUBRIS Description and Business Overview
Table 150. SALUBRIS Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 151. SALUBRIS Antibiotic API Product
Table 152. SALUBRIS Recent Developments/Updates
Table 153. KELUN Corporation Information
Table 154. KELUN Description and Business Overview
Table 155. KELUN Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 156. KELUN Antibiotic API Product
Table 157. KELUN Recent Developments/Updates
Table 158. HUAFANG PHARMACEUTICAL Corporation Information
Table 159. HUAFANG PHARMACEUTICAL Description and Business Overview
Table 160. HUAFANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 161. HUAFANG PHARMACEUTICAL Antibiotic API Product
Table 162. HUAFANG PHARMACEUTICAL Recent Developments/Updates
Table 163. Production Base and Market Concentration Rate of Raw Material
Table 164. Key Suppliers of Raw Materials
Table 165. Antibiotic API Distributors List
Table 166. Antibiotic API Customers List
Table 167. Antibiotic API Market Trends
Table 168. Antibiotic API Growth Drivers
Table 169. Antibiotic API Market Challenges
Table 170. Antibiotic API Market Restraints
Table 171. Global Antibiotic API Sales Forecast by Type (2022-2027) & (Tons)
Table 172. Global Antibiotic API Sales Market Share Forecast by Type (2022-2027)
Table 173. Global Antibiotic API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 174. Global Antibiotic API Revenue Market Share Forecast by Type (2022-2027)
Table 175. Global Antibiotic API Sales Forecast by Application (2022-2027) & (Tons)
Table 176. Global Antibiotic API Sales Market Share Forecast by Application (2022-2027)
Table 177. Global Antibiotic API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 178. Global Antibiotic API Revenue Market Share Forecast by Application (2022-2027)
Table 179. Global Antibiotic API Sales Forecast by Region (2022-2027) & (Tons)
Table 180. Global Antibiotic API Sales Market Share Forecast by Region (2022-2027)
Table 181. Global Antibiotic API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 182. Global Antibiotic API Revenue Market Share Forecast by Region (2022-2027)
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibiotic API
Figure 2. Global Antibiotic API Market Share by Type in 2020 & 2027
Figure 3. Penicillins Product Picture
Figure 4. Cephalosporins Product Picture
Figure 5. Aminoglycosides Product Picture
Figure 6. Tetracyclines Product Picture
Figure 7. Quinolones Product Picture
Figure 8. Macrolides Product Picture
Figure 9. Lincomycins Product Picture
Figure 10. Others Product Picture
Figure 11. Global Antibiotic API Market Share by Application in 2020 & 2027
Figure 12. Oral Medicine
Figure 13. Injection Medicine
Figure 14. Global Antibiotic API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Antibiotic API Market Size 2016-2027 (US$ Million)
Figure 16. Global Antibiotic API Sales 2016-2027 (Tons)
Figure 17. Global Antibiotic API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Antibiotic API Sales Share by Manufacturers in 2020
Figure 19. Global Antibiotic API Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Antibiotic API Players: Market Share by Revenue in 2020
Figure 21. Antibiotic API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Antibiotic API Sales Market Share by Region (2016-2021)
Figure 23. Global Antibiotic API Sales Market Share by Region in 2020
Figure 24. Global Antibiotic API Revenue Market Share by Region (2016-2021)
Figure 25. Global Antibiotic API Revenue Market Share by Region in 2020
Figure 26. U.S. Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Antibiotic API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Antibiotic API by Type (2016-2021)
Figure 49. Sales Market Share of Antibiotic API by Application (2016-2021)
Figure 50. Sales Market Share of Antibiotic API by Application in 2020
Figure 51. Revenue Share of Antibiotic API by Application (2016-2021)
Figure 52. Revenue Share of Antibiotic API by Application in 2020
Figure 53. Manufacturing Cost Structure of Antibiotic API
Figure 54. Manufacturing Process Analysis of Antibiotic API
Figure 55. Antibiotic API Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
